Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 16, 2024
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
Yasmeen Rahimi Maintained (VRNA) at Buy with Increased Target to $36 on, Apr 16th, 2024
Yasmeen Rahimi of Piper Sandler, Maintained "Verona Pharma plc" (VRNA) at Buy with Increased Target from $31 to $36 on, Apr 16th, 2024.
Yasmeen has made no other calls on VRNA in the last 4 months.
There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Yasmeen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Yasmeen
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Monday, March 4th, 2024
- Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $33 on, Friday, March 1st, 2024
